Piramal Enterprises’ administrative committee of its board of directors has approved raising up to Rs 500 crore through issue of non-convertible debentures on a private placement basis. The committee at its meeting approved issue of non-convertible debentures (NCDs) of up to Rs 100 crore along with an option to retain over subscription of up to Rs 400 crore, aggregating up to Rs 500 crore. The debentures are proposed to be listed on debt segment and capital market segment of National Stock Exchange (NSE) and BSE.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.
